(Q39935776)

15 September 2017

Predictors of sudden cardiac death change with time after myocardial infarction: results from the VALIANT trial (English)

1 reference

15 September 2017

myocardial infarction

1 reference

6

1 reference

15 September 2017

9

Robert M Califf

1 reference

15 September 2017

1

Jonathan P Piccini

1 reference

15 September 2017

8

John J V McMurray

1 reference

15 September 2017

5

Sana M Al-Khatib

1 reference

15 September 2017

7

Marc A Pfeffer

1 reference

15 September 2017

Min Zhang

2

1 reference

15 September 2017

Karen Pieper

series ordinal

3

1 reference

15 September 2017

Scott D Solomon

series ordinal

4

1 reference

15 September 2017

Eric J Velazquez

series ordinal

10

1 reference

15 September 2017

language of work or name

1 reference

23 October 2009

1 reference

15 September 2017

11

1 reference

based on heuristic

inferred from page(s)

published in

European Heart Journal

1 reference

15 September 2017

31

1 reference

15 September 2017

2

1 reference

15 September 2017

211-221

1 reference

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

15 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Time dependence of mortality risk and defibrillator benefit after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Analysis of survival by tumor response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

A note on a general definition of the coefficient of determination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Sudden death after myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Kidney dysfunction and sudden cardiac death among women with coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Limitations of ejection fraction for prediction of sudden death risk in patients with coronary artery disease: lessons from the MUSTT study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Identification of patients most likely to benefit from implantable cardioverter-defibrillator therapy: the Canadian Implantable Defibrillator Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

A nonidentifiability aspect of the problem of competing risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

Sudden Death in Patients with Myocardial Infarction and Left Ventricular Dysfunction, Heart Failure, or Both

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHP425

21 January 2018

Identifiers

DOI

10.1093/EURHEARTJ/EHP425

1 reference

15 September 2017

1 reference